Skip to content
AdminAug 26, 2020< 1 min read

Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight

Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new stream of cash, as it nears what will likely be the biggest test of the young company so far as the pandemic puts real-world evidence under the spotlight.

Read More

RELATED ARTICLES